Susquehanna International Group, LLP Milestone Pharmaceuticals Inc. Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.67 - $3.39 $22,209 - $45,083	13,299 New	13,299 $22,000
Q2 2023 Aug 11, 2023	BUY	$2.85 - $4.4 $30,993 - $47,850	10,875 Added 87.8%	23,261 $66,000
Q1 2023 May 16, 2023	BUY	$3.14 - $4.2 $38,892 - $52,021	12,386 New	12,386 $48,000
Q3 2022 Nov 14, 2022	BUY	$5.86 - $9.43 $164,519 - $264,747	28,075 Added 153.98%	46,308 $426,000
Q2 2022 Aug 15, 2022	BUY	$5.13 - $7.37 $41,496 - $59,615	8,089 Added 79.74%	18,233 $108,000
Q4 2020 Feb 16, 2021	BUY	$5.57 - $7.66 $56,502 - $77,703	10,144 New	10,144 $68,000

28.7M

200

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $67.5M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.